Each tablet contains 25 mg of sildenafil in the form of citrate.
MENSIL is indicated in adult men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
In order for MENSIL to be effective, sexual stimulation is required.
Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway, sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors (such as amyl nitrite) or nitrates in any form is therefore contraindicated.
The co-administration of PDE5 inhibitors, including sildenafil, with guanylate cyclase
stimulators, such as riociguat, is contraindicated as it may potentially lead to symptomatic hypotension.
Agents for the treatment of erectile dysfunction, including sildenafil, should not be used in men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure).
MENSIL MAX is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischaemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure.
The safety of sildenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated: severe hepatic impairment, hypotension (blood pressure <90/50 mmHg), recent history of stroke or myocardial infarction and known hereditary degenerative retinal disorders such as retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases). The use of sildenafil in these patients is contraindicated.
Hypersensitivity to the active substance or to any of the excipients listed below.
List of excipients:
Potassium polycriline
Anhydrous colloidal silica
Lactose monohydrate
Povidone K-30
Aspartame (E951)
Croscarmellose sodium
Mint flavour: maltodextrin, peppermint oil, sodium starch octenyl succinate (E 1450)
Magnesium stearate
Potassium hydroxide (for pH adjustment)
Hydrochloric acid (for pH adjustment)
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
Each tablet contains 25 mg of sildenafil in the form of citrate.
MENSIL is indicated in adult men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
In order for MENSIL to be effective, sexual stimulation is required.
Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway, sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors (such as amyl nitrite) or nitrates in any form is therefore contraindicated.
The co-administration of PDE5 inhibitors, including sildenafil, with guanylate cyclase
stimulators, such as riociguat, is contraindicated as it may potentially lead to symptomatic hypotension.
Agents for the treatment of erectile dysfunction, including sildenafil, should not be used in men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure).
MENSIL MAX is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischaemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure.
The safety of sildenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated: severe hepatic impairment, hypotension (blood pressure <90/50 mmHg), recent history of stroke or myocardial infarction and known hereditary degenerative retinal disorders such as retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases). The use of sildenafil in these patients is contraindicated.
Hypersensitivity to the active substance or to any of the excipients listed below.
List of excipients:
Potassium polycriline
Anhydrous colloidal silica
Lactose monohydrate
Povidone K-30
Aspartame (E951)
Croscarmellose sodium
Mint flavour: maltodextrin, peppermint oil, sodium starch octenyl succinate (E 1450)
Magnesium stearate
Potassium hydroxide (for pH adjustment)
Hydrochloric acid (for pH adjustment)
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | This cookie, set by the GDPR Cookie Consent plug-in, is used to record user consent to cookies in the "Advertising" category. | |
cookielawinfo-checkbox-analytics | A cookie used to remember the acceptance of cookies from the "Analytics" category. | |
cookielawinfo-checkbox-functional | The cookie is set by the RODO cookie consent to record the user's consent to cookies in the "Functional" category. | |
cookielawinfo-checkbox-necessary | This cookie, set by the GDPR Cookie Consent plug-in, is used to record user consent to cookies in the "Necessary" category. | |
cookielawinfo-checkbox-others | Other uncategorized cookies are those that are analyzed and have not yet been categorized. | |
cookielawinfo-checkbox-performance | This cookie is set by the GDPR Cookie Consent plugin. The cookie is used to store the user's consent to cookies in the "Performance" category. | |
CookieLawInfoConsent | Records the default button state of the corresponding category and CCPA status. It only works in coordination with the primary cookie. | |
elementor | This cookie is used by the WordPress theme of the site. It allows the site owner to implement or change the content of the site in real time. | |
viewed_cookie_policy | Records the user's consent to the use of cookies. It does not store any personal data and is recorded only on the basis of an action performed by the user (consent). |
Cookie | Duration | Description |
---|---|---|
_ga | Used to distinguish between individual users and generate statistics on how the website is used | |
_ga_* | This cookie is set by Google Analytics 4. It stores and updates a unique value for each page visited and is used to count and track page views. | |
_gat_UA-* | Google Analytics sets this cookie to track user behavior. | |
_gid | We use Google Analytics, which collects anonymous information about your visits to the site. These include such info as the sub-pages they viewed, the time they spent on the site, and the transitions between pages. |